Don L.

Don L. has had an extensive career in the pharmaceutical and chemical industries. Don currently serves as the Head of Business Development at SPI Pharma, a global supplier of ingredients for pharma formulations. Prior to this, they held various roles at Celanese, including Global Business Director and Director of Customer Applications. Don also worked at CSIRO as a Strategic Marketing & Business Development Executive, where they played a key role in identifying and capturing new partners and product concepts. Don L. also founded and led Mycogenomix, a company focused on developing novel therapeutics from genetic information. Earlier in their career, they worked at DuPont and ExxonMobil in positions related to strategic marketing, business development, and research and development.

Don L. has a diverse education history. Don began by obtaining a Bachelor of Science (B.S.) degree in Chemical and Biomolecular Engineering from the University of Tennessee, Knoxville. Following this, they pursued a Doctor of Philosophy (Ph.D.) in Chemical Engineering from Virginia Tech.

After completing their Ph.D., Don L. went on to Johannes Gutenberg University Mainz as a Post Doctoral Researcher. During this period from 1994 to 1996, they focused on Medicinal and Pharmaceutical Chemistry.

Later, Don L. attended Duke University, where they earned a Master of Business Administration (M.B.A.) degree with a specialization that is unspecified. Following their time at Duke, they briefly attended Harvard Business School in 2013, although the specific details regarding the degree and field of study are not provided.